Episodes

Investing in healthcare like we invest in curbing carbon emissions. It’s a novel idea, but something that Dr. Andrea Feigl, the Founder and CEO of Health Finance Institute, says could change the future of health, specifically chronic disease...

Mel Mann was diagnosed with a cancer known as CML and given three years to live. That was in 1995. Today, in 2023, Mel Mann is still living and still advocating – all thanks to accelerated approval and a clinical trial. Hear the story of how this...

What do patients really think about clinical trials? Do they trust them? Are they wary? Today’s episode features ., who breaks down a survey project from Patients Rising that determined some surprising results. We also speak with , a patient...

One mom’s journey into patient advocacy started after two of her daughters were diagnosed with galactosemia, a rare disease. There’s finally a potential new treatment for this condition, which families say has helped their children who have...

This week’s episode dives into the concept of running a clinical trial before ever running a clinical trial. How is that possible? It’s an idea called digital twins & we have an expert interview to break it down.  Colin Hill, CEO and Co-Founder of...

The first episode featuring our Health Plan Heroes was so good – we decided to do a second one. Listen now to see how these businesses have reinvented their health plans to provide top-tier coverage at a fraction of the cost.  Plus, did you...

It’s here! The 2023 We the Patients Fly-In is THIS WEEK and we have several Health Plan Hero Winners on the podcast to discuss their health insurance success stories as they get ready to accept their awards in person in Washington D.C. Plus, Terry...

RSV immunizations for infants are on the way, but still have a large hurdle to clear. Ronda Miller-Ernest, a pediatric nurse practitioner with more than 30 years of experience, joins us to discuss the dangers of RSV, her personal experience, and why...

UnitedHealthcare makes a confounding decision that could affect countless patients starting June 1st. Gastroenterologist Dr. Bruce Hennessy joins us to discuss how new prior authorizations for colonoscopies and other screenings could delay cancer...

C. diff, an infectious disease can be deadly for many – but especially those with compromised immune systems. We speak with a member of the Patients Rising team about their run-ins with the disease and learn how you can best protect yourself. And...

May marks National Stroke Awareness Month and this week we’re speaking with a stroke survivor who wants to make sure if a stroke ever happens to you – you’ll know all the signs. Hear Stacy Quinn’s personal story and how delaying care almost...

Another week, another middleman making it harder for patients to get the care that they need. This week, we learn more about Group Purchasing Organizations – also known as GPOs – and how they cause drug and supply shortages across the spectrum of...

So often on the Patients Rising Podcast, we discuss the affordability of healthcare. This week, guest Peter Kolchinsky outlines how thinking of paying for medicines like paying for a house mortgage leads to lower costs for patients, and encourages...

For many patients living with chronic illness the idea of “fundraising” isn’t just a child’s bakesale to pay for a field trip, it’s a necessity to pay for life-saving treatment. On this week’s podcast we speak with , Director of Outreach...

AI is having its moment in all industries, including healthcare. In this episode, hear how AI-driven tools can help oncologists treat patients. , CEO of , talks about the role of AI in care and how it helps doctors do their jobs.  And Terry and...

The ability to catch cancer early on can greatly improve a patient’s outcome. But most cancers don’t have a . That means many patients may have cancer but not show symptoms until the disease progresses. By then, treatment options may be...

Mystery healthcare prices leave patients in the dark. But thanks to hospital and insurer price transparency rules, those costs are being made public. The catch? The files that contain those prices aren’t easy for consumers to read. Health tech...

Get a look at the behind-the-scenes math that often determines whether or not insurance will cover the costs of treatments. Health technology assessments attempt to determine the value of a new treatment. But not all of these equations take into...

is one of the biggest barriers to patient care. But when employers cover transportation for patients, it can lead to better health outcomes and lower overall costs.  of explains why employers need to incorporate transportation into their health...

Vertical integration in the vision insurance market has led to higher costs and fewer options for patients. Two optometrists, and , explain how this impacts the price of your glasses, and how the DOC Access Act could fix this problem.  And Terry...

The Patients Rising Podcast has moved to Monday mornings!  In this episode, hear how , the pharmaceutical middlemen, and how potential reforms would help patients access affordable medications. gives his updates from the Sunshine State. ...

Ahead of Rare Disease Day, Congresswoman Cathy McMorris Rodgers (WA-05) joins the podcast to discuss new legislation that would ban the use of a discriminatory health care metric, quality adjusted life year, or QALY.  Learn how the QALY hurts...

Current barriers to clinical trial access make it difficult for patients from underserved communities to access cutting edge care. Those barriers include restrictive eligibility criteria, which can lead to an underrepresentation of racial and ethnic...

Stephen Kay took a job 10 hours away from his wife. Why? Because he needed insurance that would cover the costs of her multiple sclerosis care. While she had Medicare before turning 65, she was unable to purchase a supplemental plan, or Medigap plan,...